Israel - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingIsrael: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in Israel
In 2021, the Israeli medicaments containing insulin market decreased by -0.8% to $X, falling for the fifth year in a row after two years of growth. Over the period under review, consumption, however, posted a buoyant increase. Over the period under review, the market reached the maximum level at $X in 2016; however, from 2017 to 2021, consumption failed to regain momentum.
Medicaments Containing Insulin Production in Israel
In value terms, medicaments containing insulin production skyrocketed to $X in 2021 estimated in export price. Over the period under review, production, however, showed a significant increase. The most prominent rate of growth was recorded in 2019 when the production volume increased by 118%. As a result, production attained the peak level of $X. From 2020 to 2021, production growth remained at a somewhat lower figure.
Medicaments Containing Insulin Exports
Exports from Israel
In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -42.8% to X kg, falling for the second year in a row after eight years of growth. In general, exports, however, posted a significant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 181%. As a result, the exports reached the peak of X tons. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.
In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Overall, exports, however, posted buoyant growth. The growth pace was the most rapid in 2019 with an increase of 55%. As a result, the exports reached the peak of $X. From 2020 to 2021, the growth of the exports remained at a lower figure.
Exports by Country
Guatemala (X kg) was the main destination for medicaments containing insulin exports from Israel, accounting for a approx. 100% share of total exports.
From 2012 to 2021, the average annual growth rate of volume to Guatemala was relatively modest.
In value terms, Palestine ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from Israel, comprising 100% of total exports. The second position in the ranking was held by Guatemala ($X), with a 0.1% share of total exports.
From 2012 to 2021, the average annual rate of growth in terms of value to Palestine amounted to +14.6%.
Export Prices by Country
In 2021, the average medicaments containing insulin export price amounted to $X per ton, rising by 34% against the previous year. In general, the export price, however, recorded a abrupt shrinkage. Over the period under review, the average export prices hit record highs at $X per ton in 2013; however, from 2014 to 2021, the export prices failed to regain momentum.
As there is only one major export destination, the average price level is determined by prices for Guatemala.
From 2013 to 2021, the rate of growth in terms of prices for Guatemala amounted to 0.0% per year.
Medicaments Containing Insulin Imports
Imports into Israel
In 2021, after two years of decline, there was significant growth in supplies from abroad of medicaments containing insulin but not antibiotics, when their volume increased by 133% to X kg. In general, imports, however, showed a slight contraction. The growth pace was the most rapid in 2014 when imports increased by 535% against the previous year. Over the period under review, imports reached the maximum at X kg in 2015; however, from 2016 to 2021, imports remained at a lower figure.
In value terms, medicaments containing insulin imports soared to $X in 2021. Overall, imports recorded buoyant growth. The pace of growth was the most pronounced in 2014 with an increase of 400% against the previous year. Over the period under review, imports hit record highs at $X in 2015; however, from 2016 to 2021, imports failed to regain momentum.
Imports by Country
From 2012 to 2021, the average annual rate of growth in terms of volume from No country was relatively modest.
In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Israel.
From 2012 to 2021, the average annual growth rate of value from the United States stood at +31.9%.
Import Prices by Country
In 2018, the average medicaments containing insulin import price amounted to $X per ton, jumping by 29% against the previous year. Over the period under review, the import price posted a prominent increase. The pace of growth appeared the most rapid in 2016 an increase of 72% against the previous year. Over the period under review, average import prices reached the maximum in 2018 and is expected to retain growth in the immediate term.
As there is only one major supplying country, the average price level is determined by prices for the United States.
From 2013 to 2018, the rate of growth in terms of prices for the United States amounted to 0.0% per year.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Israel. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Israel
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Israel
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
- Market Research in Israel
- Medicaments Containing Insulin Market
- Polymer Ion-exchangers Market
- Phenolphthalein and Lactones Market
- Hydantoin Market
- Malonylurea and Its Derivatives Market
- Compounds Containing A Pyrimidine Ring Market
- Compounds Containing An Unfused Triazine Ring Market
- Compounds Containing A Phenothiazine Ring-system Market
- Sulphonamides Market